Cimetidine: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 March 2024

17 March 2024

  • curprev 20:5720:57, 17 March 2024‎ Lazy talk contribs‎ 656 bytes −2‎ No edit summary Tag: Manual revert
  • curprev 20:5120:51, 17 March 2024‎ Lazy talk contribs‎ 658 bytes +2‎ No edit summary Tag: Reverted
  • curprev 20:5020:50, 17 March 2024‎ Lazy talk contribs‎ 656 bytes +656‎ Created page with "{{TreatmentInfo |drug_name=Cimetidine (Tagamet) |FDA_approval=Yes (for stomach conditions, not specifically approved for brain cancer yet) |used_for=Experimental for glioblastoma; approved for stomach acid reduction; noted use in colon cancer |mechanism_of_action=Decreases cell migration by affecting genes controlling cellular adhesion |clinical_trial_year=Recent (specific year not mentioned) |number_of_patients=N/A (mouse study) |median_survival=Substantially longer sur..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Cimetidine"